Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00B52SFT06
| Stock Name / Fund | iShares MSCI USA UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares VII Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300Q7FFITMZ2PFZ28 |
| ETF Ticker | CU1(GBX) LSE |
| ETF Ticker | SXR4(EUR) F |
| ETF Ticker | CSUS.LS(USD) CXE |
| ETF Ticker | CSUS.MI(EUR) CXE |
| ETF Ticker | CSUSz(USD) CXE |
| ETF Ticker | SXR4.DE(EUR) CXE |
| ETF Ticker | CSUS(EUR) Euronext Amsterdam |
| ETF Ticker | CU1.L(GBP) LSE |
Holdings detail for UTHR
| Stock Name | United Therapeutics Corporation |
| Ticker | UTHR(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US91307C1027 |
| LEI | 5299005C4HZL4UWROC14 |
Show aggregate UTHR holdings
News associated with UTHR
- Cantor Fitzgerald Increases United Therapeutics (NASDAQ:UTHR) Price Target to $525.00
- United Therapeutics (NASDAQ:UTHR – Free Report) had its target price lifted by Cantor Fitzgerald from $405.00 to $525.00 in a research note published on Wednesday morning,Benzinga reports. Cantor Fitzgerald currently has an overweight rating on the biotechnology company’s stock. A number of other equities analysts also recently issued reports on the company. Jefferies Financial Group […] - 2025-09-11 04:46:17
- United Therapeutics (NASDAQ:UTHR) Price Target Raised to $575.00 at Oppenheimer
- United Therapeutics (NASDAQ:UTHR – Free Report) had its price objective raised by Oppenheimer from $510.00 to $575.00 in a research report released on Friday morning,Benzinga reports. The firm currently has an outperform rating on the biotechnology company’s stock. Several other analysts have also weighed in on the company. JPMorgan Chase & Co. cut their price […] - 2025-09-08 02:46:57
- HC Wainwright Increases United Therapeutics (NASDAQ:UTHR) Price Target to $500.00
- United Therapeutics (NASDAQ:UTHR – Free Report) had its target price upped by HC Wainwright from $400.00 to $500.00 in a research note published on Friday morning,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. HC Wainwright also issued estimates for United Therapeutics’ FY2027 earnings at $28.37 EPS. Several other analysts […] - 2025-09-08 02:46:54
- United Therapeutics Corporation (NASDAQ:UTHR) Short Interest Up 82.2% in August
- United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) saw a significant increase in short interest in the month of August. As of August 15th, there was short interest totaling 2,860,000 shares, anincreaseof82.2% from the July 31st total of 1,570,000 shares. Currently,6.5% of the shares of the company are short sold. Based on an average daily […] - 2025-09-08 02:15:08
- United Therapeutics (NASDAQ:UTHR) Shares Down 4.8% Following Insider Selling
- United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) shares were down 4.8% during mid-day trading on Wednesday following insider selling activity. The stock traded as low as $385.50 and last traded at $385.45. Approximately 497,022 shares were traded during trading, a decline of 9% from the average daily volume of 547,000 shares. The stock had […] - 2025-09-05 02:16:54
- Insider Selling: United Therapeutics (NASDAQ:UTHR) Director Sells 3,000 Shares of Stock
- United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) Director Christopher Causey sold 3,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $423.21, for a total value of $1,269,630.00. Following the transaction, the director owned 4,865 shares in the company, valued […] - 2025-09-04 05:22:59
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 14:33:33
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 13:44:52
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 12:52:53
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 12:27:04
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 10:14:11
- UTHR Crosses Above Average Analyst Target
- In recent trading, shares of United Therapeutics Corp (Symbol: UTHR) have crossed above the average analyst 12-month target price of $382.58, changing hands for $404.81/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgr - 2025-09-03 08:28:18
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 08:10:07
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 06:59:07
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 05:15:06
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 04:43:16
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 03:40:04
- Stocks Retreat as Bond Yields Climb
- The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down by -0.69%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.79%. September E-mini S&P futures (ESU25 ) fell -0.65%, and September... - 2025-09-03 01:21:35
- Stocks Tumble on Higher Bond Yields
- The S&P 500 Index ($SPX ) (SPY ) today is down by -1.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.38%. September E-mini S&P futures (ESU25 ) are down -1.25%, and September... - 2025-09-02 20:15:06
- Stocks Under Pressure from Higher Bond Yields
- The S&P 500 Index ($SPX ) (SPY ) today is down by -1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.83%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.32%. September E-mini S&P futures (ESU25 ) are down -1.15%, and September... - 2025-09-02 17:45:25
- Stocks Under Pressure from Higher Bond Yields
- The S&P 500 Index ($SPX ) (SPY ) today is down by -1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.83%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.32%. September E-mini S&P futures (ESU25 ) are down -1.15%, and September... - 2025-09-02 13:49:14
- Stocks Tumble on Higher Bond Yields
- The S&P 500 Index ($SPX ) (SPY ) today is down by -1.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.38%. September E-mini S&P futures (ESU25 ) are down -1.25%, and September... - 2025-09-02 13:32:33
- Stocks Tumble on Higher Bond Yields
- The S&P 500 Index ($SPX ) (SPY ) today is down by -1.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -1.38%. September E-mini S&P futures (ESU25 ) are down -1.25%, and September... - 2025-09-02 12:50:37
- United Therapeutics (NASDAQ:UTHR) EVP Paul Mahon Sells 11,000 Shares
- United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) EVP Paul Mahon sold 11,000 shares of the company’s stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $308.75, for a total transaction of $3,396,250.00. Following the sale, the executive vice president directly owned 36,781 shares of the company’s […] - 2025-08-25 05:07:00
- LABU, INCY, UTHR, REGN: ETF Outflow Alert
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
- Analysts Set United Therapeutics Corporation (NASDAQ:UTHR) PT at $379.69
- United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) has earned an average recommendation of “Moderate Buy” from the thirteen research firms that are covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1-year target price among analysts […] - 2025-08-15 02:40:53
- Deutsche Bank AG Cuts Stake in United Therapeutics Corporation (NASDAQ:UTHR)
- Deutsche Bank AG lessened its position in United Therapeutics Corporation (NASDAQ:UTHR – Free Report) by 6.4% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 134,483 shares of the biotechnology company’s stock after selling 9,146 shares during the period. Deutsche Bank AG […] - 2025-08-13 04:52:49
- Notable Thursday Option Activity: TGT, UTHR, ENPH
- Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Target Corp (Symbol: TGT), where a total of 35,810 contracts have traded so far, representing approximately 3.6 million underlying shares. That amounts to about 72% of T - 2025-08-07 16:22:01
- 977 Shares in United Therapeutics Corporation (NASDAQ:UTHR) Purchased by Arkadios Wealth Advisors
- Arkadios Wealth Advisors purchased a new stake in United Therapeutics Corporation (NASDAQ:UTHR – Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 977 shares of the biotechnology company’s stock, valued at approximately $301,000. Other hedge funds and other institutional […] - 2025-08-07 05:06:52
- Mackenzie Financial Corp Sells 51 Shares of United Therapeutics Corporation (NASDAQ:UTHR)
- Mackenzie Financial Corp trimmed its holdings in shares of United Therapeutics Corporation (NASDAQ:UTHR – Free Report) by 1.9% during the first quarter, Holdings Channel.com reports. The institutional investor owned 2,606 shares of the biotechnology company’s stock after selling 51 shares during the quarter. Mackenzie Financial Corp’s holdings in United Therapeutics were worth $803,000 at the […] - 2025-08-06 05:07:40
iShares MSCI USA UCITS ETF USD (Acc) UTHR holdings
| Date | Number of UTHR Shares Held | Base Market Value of UTHR Shares | Local Market Value of UTHR Shares | Change in UTHR Shares Held | Change in UTHR Base Value | Current Price per UTHR Share Held | Previous Price per UTHR Share Held |
|---|
| 2025-09-18 (Thursday) | 1,780 | USD 729,569 | USD 729,569 | 0 | USD 11,019 | USD 409.87 | USD 403.68 |
| 2025-09-17 (Wednesday) | 1,780 | USD 718,550 | USD 718,550 | 0 | USD 10,163 | USD 403.68 | USD 397.97 |
| 2025-09-16 (Tuesday) | 1,780 | USD 708,387 | USD 708,387 | 0 | USD -9,149 | USD 397.97 | USD 403.11 |
| 2025-09-15 (Monday) | 1,780 | USD 717,536 | USD 717,536 | 7 | USD -564 | USD 403.11 | USD 405.02 |
| 2025-09-12 (Friday) | 1,773 | USD 718,100 | USD 718,100 | -7 | USD -2,515 | USD 405.02 | USD 404.84 |
| 2025-09-11 (Thursday) | 1,780 | USD 720,615 | USD 720,615 | 0 | USD 14,845 | USD 404.84 | USD 396.5 |
| 2025-09-10 (Wednesday) | 1,780 | USD 705,770 | USD 705,770 | 0 | USD -12,994 | USD 396.5 | USD 403.8 |
| 2025-09-09 (Tuesday) | 1,780 | USD 718,764 | USD 718,764 | 0 | USD 16,340 | USD 403.8 | USD 394.62 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of UTHR by Blackrock for IE00B52SFT06
Show aggregate share trades of UTHR| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-09-15 | BUY | 7 | | | 403.110* | | 328.24 |
| 2025-09-12 | SELL | -7 | | | 405.020* | | 327.79 Profit of 2,295 on sale |
| 2025-09-05 | BUY | 7 | | | 400.520* | | 325.57 |
| 2025-07-17 | SELL | -7 | | | 297.330* | | 326.52 Profit of 2,286 on sale |
| 2025-07-15 | SELL | -7 | | | 293.240* | | 326.91 Profit of 2,288 on sale |
| 2025-07-10 | BUY | 14 | | | 300.160* | | 327.49 |
| 2025-07-02 | BUY | 14 | | | 295.220* | | 328.83 |
| 2025-06-27 | BUY | 21 | | | 284.270* | | 329.42 |
| 2025-05-28 | SELL | -7 | | | 315.640* | | 334.13 Profit of 2,339 on sale |
| 2025-04-14 | BUY | 13 | | | 284.310* | | 346.43 |
| 2025-04-11 | BUY | 13 | | | 281.160* | | 347.15 |
| 2025-04-04 | SELL | -286 | | | 292.460* | | 350.68 Profit of 100,296 on sale |
| 2025-03-19 | SELL | -13 | | | 318.850* | | 356.39 Profit of 4,633 on sale |
| 2025-03-17 | SELL | -13 | | | 322.940* | | 357.44 Profit of 4,647 on sale |
| 2025-03-12 | BUY | 26 | | | 307.090* | | 359.65 |
| 2025-03-11 | BUY | 26 | | | 304.420* | | 360.47 |
| 2025-03-10 | BUY | 78 | | | 317.870* | | 361.10 |
| 2025-03-07 | BUY | 26 | | | 315.910* | | 361.79 |
| 2025-03-06 | BUY | 13 | | | 307.680* | | 362.62 |
| 2025-03-05 | BUY | 13 | | | 310.980* | | 363.43 |
| 2025-03-04 | BUY | 39 | | | 308.590* | | 364.30 |
| 2025-03-03 | BUY | 26 | | | 310.030* | | 365.17 |
| 2025-02-27 | BUY | 65 | | | 323.620* | | 366.62 |
| 2025-02-26 | BUY | 26 | | | 318.890* | | 367.43 |
| 2025-02-18 | BUY | 39 | | | 372.830* | | 367.55 |
| 2025-02-05 | BUY | 13 | | | 354.180* | | 369.17 |
| 2025-01-31 | BUY | 13 | | | 351.170* | | 370.35 |
| 2024-12-30 | BUY | 26 | | | 357.640* | | 371.46 |
| 2024-11-20 | BUY | 52 | | | 364.330* | | 371.92 |
| 2024-11-18 | BUY | 65 | | | 359.210* | | 373.42 |
| 2024-11-12 | BUY | 13 | | | 400.870* | | 371.59 |
| 2024-11-07 | BUY | 65 | | | 402.570* | | 366.25 |
| 2024-10-24 | BUY | 13 | | | 350.190* | | 364.48 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of UTHR
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 153,866 | 0 | 219,485 | 70.1% |
| 2025-09-18 | 150,660 | 507 | 244,012 | 61.7% |
| 2025-09-17 | 118,604 | 0 | 203,933 | 58.2% |
| 2025-09-16 | 98,017 | 0 | 152,204 | 64.4% |
| 2025-09-15 | 194,904 | 1,100 | 272,093 | 71.6% |
| 2025-09-12 | 140,200 | 312 | 215,877 | 64.9% |
| 2025-09-11 | 130,761 | 0 | 185,960 | 70.3% |
| 2025-09-10 | 93,471 | 0 | 167,479 | 55.8% |
| 2025-09-09 | 130,474 | 5,137 | 237,469 | 54.9% |
| 2025-09-08 | 133,051 | 155 | 197,596 | 67.3% |
| 2025-09-05 | 208,712 | 0 | 305,636 | 68.3% |
| 2025-09-04 | 267,014 | 2,931 | 447,449 | 59.7% |
| 2025-09-03 | 353,287 | 6,339 | 607,921 | 58.1% |
| 2025-09-02 | 588,583 | 649 | 1,051,870 | 56.0% |
| 2025-08-29 | 83,066 | 0 | 153,416 | 54.1% |
| 2025-08-28 | 189,688 | 0 | 274,930 | 69.0% |
| 2025-08-27 | 106,544 | 0 | 190,443 | 55.9% |
| 2025-08-26 | 205,626 | 1 | 291,359 | 70.6% |
| 2025-08-25 | 169,978 | 50 | 284,574 | 59.7% |
| 2025-08-22 | 111,768 | 0 | 168,756 | 66.2% |
| 2025-08-21 | 108,127 | 700 | 171,869 | 62.9% |
| 2025-08-20 | 97,311 | 0 | 233,032 | 41.8% |
| 2025-08-19 | 101,665 | 0 | 173,996 | 58.4% |
| 2025-08-18 | 117,218 | 0 | 198,427 | 59.1% |
| 2025-08-15 | 102,775 | 400 | 182,428 | 56.3% |
| 2025-08-14 | 111,383 | 2 | 241,644 | 46.1% |
| 2025-08-13 | 121,320 | 20 | 207,808 | 58.4% |
| 2025-08-12 | 119,055 | 0 | 255,456 | 46.6% |
| 2025-08-11 | 66,961 | 2 | 172,485 | 38.8% |
| 2025-08-08 | 80,618 | 0 | 168,980 | 47.7% |
| 2025-08-07 | 127,929 | 300 | 188,828 | 67.7% |
| 2025-08-06 | 133,246 | 0 | 198,721 | 67.1% |
| 2025-08-05 | 167,281 | 0 | 265,699 | 63.0% |
| 2025-08-04 | 129,417 | 0 | 261,825 | 49.4% |
| 2025-08-01 | 233,117 | 0 | 390,876 | 59.6% |
| 2025-07-31 | 124,812 | 82 | 221,740 | 56.3% |
| 2025-07-30 | 202,980 | 2,630 | 356,973 | 56.9% |
| 2025-07-29 | 86,445 | 121 | 209,016 | 41.4% |
| 2025-07-28 | 88,897 | 370 | 186,606 | 47.6% |
| 2025-07-25 | 62,507 | 0 | 105,428 | 59.3% |
| 2025-07-24 | 87,550 | 1,026 | 144,035 | 60.8% |
| 2025-07-23 | 91,947 | 14 | 184,045 | 50.0% |
| 2025-07-22 | 60,147 | 0 | 122,296 | 49.2% |
| 2025-07-21 | 77,937 | 42 | 134,589 | 57.9% |
| 2025-07-18 | 68,061 | 154 | 93,661 | 72.7% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.